IDEAYA Biosciences (IDYA) Assets (2018 - 2026)
IDEAYA Biosciences (IDYA) recorded Assets of $1.31 billion in Q2 2026, up 25.8% from $1.04 billion a year earlier and up 27.1% from the prior quarter.
Powered by 
Analysis
IDEAYA Biosciences (IDYA) Assets (2018 - 2026) Analysis & Trends
At the end of FY2025, IDEAYA Biosciences reported Assets of $1.11 billion, down 1.3% from FY2024.
- Annual Assets has a five-year compound annual growth rate of 30.0% (FY2020 to FY2025).
- Across earlier years, Assets came in at $1.12 billion in FY2024 (+73.1%), $649.32 million in FY2023 (+67.4%), $387.97 million in FY2022 (+1.7%) and $381.35 million in FY2021 (+27.9%).
- The Q2 2026 figure is the highest quarterly Assets in data going back to Q4 2018.
- On a year-over-year basis, Assets rose in five of the last eight quarters, with growth averaging 30.1%.
- Peak year-over-year performance for Assets in the last five years was growth of 163.6% in Q1 2024, against a decline of 6.4% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.03 billion (Q1 2026), $1.11 billion (Q4 2025) and $1.19 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | IDEAYA Biosciences | 3.68 Bn | 757.04 Mn | - | 1.31 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.31 Bn |
| Mar 31, 2026 | 1.03 Bn |
| Dec 31, 2025 | 1.11 Bn |
| Sep 30, 2025 | 1.19 Bn |
| Jun 30, 2025 | 1.04 Bn |
| Mar 31, 2025 | 1.10 Bn |
| Dec 31, 2024 | 1.12 Bn |
| Sep 30, 2024 | 1.24 Bn |
| Jun 30, 2024 | 973.66 Mn |
| Mar 31, 2024 | 961.53 Mn |
| Dec 31, 2023 | 649.32 Mn |
| Sep 30, 2023 | 532.94 Mn |
| Jun 30, 2023 | 527.56 Mn |
| Mar 31, 2023 | 364.75 Mn |
| Dec 31, 2022 | 387.97 Mn |
| Sep 30, 2022 | 410.91 Mn |
| Jun 30, 2022 | 338.01 Mn |
| Mar 31, 2022 | 358.87 Mn |
| Dec 31, 2021 | 381.35 Mn |
| Sep 30, 2021 | 399.44 Mn |
API Access
IDEAYA Biosciences Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=IDYA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "IDYA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=IDYA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();